Prevalence and Predictors ofToxoplasmaSeropositivity in Women with and at Risk for Human Immunodeficiency Virus Infection
Author(s) -
Oluwatoyin M. Falusi,
Audrey L. French,
Eric C. Seaberg,
Phyllis C. Tien,
D. Heather Watts,
Howard Minkoff,
Eva Piessens,
Andrea Kovács,
Kathryn Anastos,
Mardge H. Cohen
Publication year - 2002
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/344462
Subject(s) - medicine , human immunodeficiency virus (hiv) , immunology , virology , environmental health
We assessed the prevalence and predictors of latent Toxoplasma infection in a large group of human immunodeficiency virus (HIV)-infected and HIV-uninfected at-risk US women. The prevalence of latent Toxoplasma infection was 15% (380 of 2525 persons) and did not differ by HIV infection status. HIV-infected women aged > or =50 years and those born outside of the United States were more likely to have latent Toxoplasma infection, with prevalences of 32% and 41%, respectively.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom